Fund Holdings — Pivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value
$172.98M
Total Bought
$18.12M
Total Sold
$23.64M
Net Transaction
-$5.52M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ARCUTIS BIOTHERAPEUTICS INC(ARQT)2,120,5082,120,508029,73039,97223.11%+10,242
ZENAS BIOPHARMA INC(ZBIO)779,045779,04507,54917,29510.00%+9,746
VAXCYTE INC(PCVX)1,305,1251,372,425+67,30042,43049,43528.58%+7,005
IMMUNOME INC(IMNM)0502,512+502,51205,8843.40%+5,884
TREVI THERAPEUTICS INC(TRVI)1,146,1101,256,782+110,6726,26911,5006.65%+5,230
BIOAGE LABS INC(BIOA)653,374653,37402,6983,8422.22%+1,143
RALLYBIO CORP(RLYB)2,404,6442,404,64408131,2000.69%+387
BOLT BIOTHERAPEUTICS INC94,57394,57305465030.29%-43
RECURSION PHARMACEUTICALS IN(RXRX)595,518595,51803,0132,9061.68%-107
IO BIOTECH INC(IOBTQ)864,1970-864,1971,2010—-1,201
OCULIS HOLDING AG(OCS)2,300,7742,300,774044,65840,44823.38%-4,210
VIGIL NEUROSCIENCE INC560,5950-560,5954,4570—-4,457
INOZYME PHARMA INC4,494,8510-4,494,85117,9790—-17,979
Page 1 of 1
Pivotal bioVenture Partners Investment Advisor LLC — 13F Holdings — Q3 2025 | TickerTrail